TULANE UNIVERSITY OF LOUISIANA
Potent Boosting of Tfh1 Cells to Enhance HIV-1 Vaccine Efficacy
Potent Boosting of Tfh1 Cells to Enhance HIV-1 Vaccine Efficacy is a funding opportunity from TULANE UNIVERSITY OF LOUISIANA, up to 1540805, closing March 31, 2027.
Mar 31, 2027
(243d left)Overview
The development of effective HIV vaccines and other prevention strategies relies on the use of nonhuman primates (NHPs) in preclinical studies. To meet this need, the Simian Vaccine Evaluation Units (SVEUs) provide NHP resources that primarily support preclinical evaluation of AIDS vaccines and prevention modalities.…